kw.\*:("CLOBETASOL PROPIONATE")
Results 1 to 25 of 159
Selection :
Different treatment outcomes with different formulations of clobetasol propionate 0.05% for the treatment of plaque psoriasisMRAZ, Serena; LEONARDI, Craig; COLON, Luz E et al.Journal of dermatological treatment. 2008, Vol 19, Num 6, pp 354-359, issn 0954-6634, 6 p.Article
Topical Monotherapy With Clobetasol Propionate Spray 0.05% in the COBRA TrialMENTER, Alan.Cutis (New York, NY). 2007, Vol 80, Num 5, pp 12-19, issn 0011-4162, 8 p., SUPArticle
OBSERVATIONS ON THE SYSTEMIC EFFECT OF TOPICAL CLOBETASOL PROPIONATE (DERMOVATE). = OBSERVATIONS SUR L'EFFET SYSTEMIQUE DU CLOBETASOL PROPIONATE EN APPLICATION LOCALECARRUTHERS JA; AUGUST PJ; STAUGHTON RCD et al.1975; BRIT. MED. J.; G.B.; DA. 1975; NO 5990; PP. 203-204; BIBL. 9 REF.Article
Effectiveness of Clobetasol Propionate Spray 0.05% Added to Other Stable Treatments : Add-on Therapy in the COBRA TrialFELDMAN, Steven R.Cutis (New York, NY). 2007, Vol 80, Num 5, pp 20-28, issn 0011-4162, 9 p., SUPArticle
EFFECTS ON ADRENAL FUNCTION OF TOPICALLY APPLIED CLOBETASOL PROPIONATE (DERMOVATE) = EFFET SUR LA FONCTION SURRENALIENNE DU PROPIONATE DE CLOBETASOL (DERMOVATE) APPLIQUE LOCALEMENTALLENBY CF; MAIN RA; MARSDEN RA et al.1975; BRIT. MED. J.; G.B.; DA. 1975; NO 5997; PP. 619-621; BIBL. 17 REF.Article
Pharmacokinetics study about topical clobetasol on oral mucosaVARONI, Elena M; MOLTENI, Alessia; SARDELLA, Andrea et al.Journal of oral pathology & medicine. 2012, Vol 41, Num 3, pp 255-260, issn 0904-2512, 6 p.Article
Cushing syndrome caused by topical corticosteroid : A case reportGEN, Ramazan; AKBAY, Esen; SEZER, Kerem et al.The American journal of the medical sciences. 2007, Vol 333, Num 3, pp 173-174, issn 0002-9629, 2 p.Article
Clobetasol Propionate Shampoo 0.05% Is Efficacious and Safe for Long-term Control of Scalp PsoriasisPOULIN, Yves; PAPP, Kim; BISSONNETTE, Robert et al.Cutis (New York, NY). 2010, Vol 85, Num 1, pp 43-50, issn 0011-4162, 8 p.Article
Trichostasis spinulosa : possible association with prolonged topical application of clobetasol propionate 0.05% creamJANJUA, Shahbaz A; MCKOY, Karen C; IFTIKHAR, Nadia et al.International journal of dermatology. 2007, Vol 46, Num 9, pp 982-985, issn 0011-9059, 4 p.Article
VERGLEICHENDE STUDIEN ZWISCHEN CLOBETASOL-17-PROPIONAT UND ANDEREN GEBRAEUCHLICHEN KORTIKOID-EXTERNA IM DOPPELBLINDVERSUCH = ETUDES COMPARATIVES ENTRE LE 17-PROPIONATE DE CLOBETASOL ET LES AUTRES POMMADES CORTICOIDES USUELLES DANS UNE EXPERIENCE EN DOUBLE AVEUGLEBECK M; BERGER C; FILIPP N et al.1981; H+G, Z. HAUTKR.; ISSN 0301-0481; DEU; DA. 1981; VOL. 56; NO 16; PP. 1066-1070; 5 P.; ABS. ENG; BIBL. 3 REF.Article
IL CLOBETASOLO 17-PROPIONATO NEL TRATTAMENTO DELLA PSORIASI E DELLE DERMATITI ECZEMATOSE: VALUTAZIONE CLINICA DELL' ATTIVITA TERAPEUTICA = LE PROPIONATE 17 DE CLOBETASOL DANS LE TRAITEMENT DU PSORIASIS ET DES DERMATOSES ECZEMATEUSES. EVALUATION CLINIQUE DE L'ACTIVITE THERAPEUTIQUEGOITRE M; FORTE M; SARTORIS S et al.1979; G. ITAL. DERMATOL., MINERVA DERMATOL.; ITA; DA. 1979; VOL. 114; NO 11; PP. 631-636; ABS. ENG; BIBL. 27 REF.Article
INTERMITTENT TREATMENT OF PSORIASIS WITH CLOBETASOL PROPIONATEHRADIL E; LINDSTROM C; MOLLER H et al.1978; ACTA DERMATO-VENEREOL.; SWE; DA. 1978; VOL. 58; NO 4; PP. 375-377; BIBL. 5 REF.Article
TOPICAL CLOBETASOL PROPIONATE IN THE TREATMENT OF SCALP PSORIASIS: A MEDIUM TERM FOLLOW-UPZAR E.1980; CURR. THER. RES.; ISSN 0011-393X; USA; DA. 1980; VOL. 28; NO 6; PART. 2; PP. 997-1001; BIBL. 12 REF.Article
A PROPOS D'UN NOUVEAU CORTICOIDE A USAGE LOCAL: NOUVEAU. VRAIMENT.RUDLOFF J.1980; OUEST MED.; FRA; DA. 1980; VOL. 33; NO 8; PP. 407-408Article
COMPARISON OF CLOBETASOL PROPIONATE AND BETAMETHASONE-17,21-DIPROPIONATE WITH REFERENCE TO ADRENAL SUPPRESSIONERIKSEN K.1979; ACTA DERMATO-VENEREOL.; SWE; DA. 1979; VOL. 59; NO 4; PP. 372-374; BIBL. 13 REF.Article
EFFECTS OF GLUCOCORTICOSTEROIDS ON CULTURED HUMAN SKIN FIBROBLASTS. V: INFLUENCE OF ANABOLIC STEROIDS ON THE INHIBITORY EFFECTS OF CLOBETASOL-17-PROPIONATE ON CELL PROLIFERATION AND COLLAGEN SYNTHESISPONEC M; DE HAAS C; KEMPENAAR JA et al.1979; ARCH. DERMATOL. RES.; DEU; DA. 1979; VOL. 266; NO 1; PP. 75-82; ABS. GER; BIBL. 12 REF.Article
ESSAI THERAPEUTIQUE EN DERMATOLOGIE DU PROPIONATE DE CLOBETASOLBOULLIE MC; BRAVARD P; FLECHET ML et al.1980; OUEST MED.; ISSN 0048-2366; FRA; DA. 1980; VOL. 33; NO 21; PP. 1193-1194Conference Paper
ESSAIS CLINIQUES D'UN NOUVEAU DERMOCORTICOIDE: LA PROPIONATE DE CLOBETASOLAMBLARD P; JEROME P.1980; REV. MED. ALPES FR.; FRA; DA. 1980; VOL. 9; NO 1-2; PP. 47-49Article
THE TREATMENT OF ACTIVE CHRONIC PSORIASIS. A COMPARISON OF THE EFFECTIVENESS OF A PREPARATION CONTAINING 0.1% DITHRANOL PLUS 17% UREA (PSORADRATE) AND 0.05% CLOBETASOL PROPIONATE (DERMOVATE)MACKEY JP; BARNES J.1978; CLIN. TRIALS J.; GBR; DA. 1978; VOL. 15; NO 4; PP. 113-118; BIBL. 15 REF.Article
Clobetasol propionate ointment 0.05 % versus diflorasone diacetate ointment 0.05 % in moderate to severe psoriasisJEGASOTHY, B. V.International journal of dermatology. 1990, Vol 29, Num 10, pp 729-730, issn 0011-9059, 2 p.Article
INTRALYMPHATIC STEROID THERAPY FOR LYMPHOEDEMA: PRELIMINARY STUDIESFYFE NCM; RUTT DL; EDWARDS JM et al.1982; LYMPHOLOGY; ISSN 0024-7766; DEU; DA. 1982; VOL. 15; NO 1; PP. 23-28; BIBL. 14 REF.Article
THE MEASUREMENT OF CORTICOSTEROID INDUCED DERMAL ATROPHY BY A RADIOLOGICAL METHOD = MESURE DE L'ATROPHIE CUTANEE INDUITE PAR LES CORTICOSTEROIDES EN UTILISANT UNE METHODE RADIOLOGIQUEMARKS R; DYKES PJ; ROBERTS E et al.1975; ARCH. DERMATOL. RES.; GERM.; DA. 1975; VOL. 253; NO 2; PP. 93-96; ABS. ALLEM.; BIBL. 8 REF.Article
ETUDE SUR LA TOXICITE DU PROPIONATE-17 DE CLOBETASOL. IV. OBSERVATIONS AU MICROSCOPE ELECTRONIQUE SUR LA RESTAURATION DES TISSUS ALTERES APRES INJECTIONS SOUS-CUTANEES QUOTIDIENNES DE PROPIONATE-17 DE CLOBETASOL CHEZ LE RAT PENDANT 3 MOIS CONSECUTIFSKURAMOTO M; ISHIMURA Y; SHIUNG YI LEE et al.1975; SHIKOKU ACTA MED.; JAP.; DA. 1975; VOL. 32; NO 6; PP. 429-435; ABS. ANGL.; BIBL. 4 REF.Article
A randomized, investigator-masked clinical evaluation of the efficacy and safety of clobetasol propionate 0.05% shampoo and tar blend 1% shampoo in the treatment of moderate to severe scalp psoriasisGRIFFITHS, Christopher E. M; FINLAY, Andrew Y; FLEMING, Colin J et al.Journal of dermatological treatment. 2006, Vol 17, Num 2, pp 90-95, issn 0954-6634, 6 p.Article
An Open-Label, Multicenter Study of the Efficacy and Safety of an AM/PM Treatment Regimen With Clobetasol Propionate Spray 0.05% and Calcitriol Ointment 3 μg/g in the Management of Plaque PsoriasisMENTER, Alan; SOFEN, Howard; SMITH, Stacy et al.Cutis (New York, NY). 2011, Vol 88, Num 1, pp 46-51, issn 0011-4162, 6 p.Article